help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on April 1, 2008
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-2619
A more recent version of this article appeared on June 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
93/6/2277    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gjedde, S.
Right arrow Articles by Jørgensen, J. O. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gjedde, S.
Right arrow Articles by Jørgensen, J. O. L.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*LEVOTHYROXINE
Related Collections
Right arrow Thyroid
Right arrow Metabolism

Submitted on November 27, 2007
Accepted on March 24, 2008

Serum ghrelin levels are increased in hypothyroid patients and become normalized by L-thyroxin treatment

Signe Gjedde*, Esben Thyssen Vestergaard, Lars Christian Gormsen, Anne Lene Dalkjær Riis, Jørgen Rungby, Niels Møller, Jørgen Weeke, and Jens Otto Lunde Jørgensen

Medical Department M (Endocrinology & Diabetes), Aarhus University Hospital, DK-8000 Aarhus, Denmark; Department of Clinical Physiology and Nuclear Medicine, Aarhus University Hospital, DK-8000 Aarhus, Denmark; Medical Department C and Department of Pharmacology, Aarhus University Hospital, DK-8000 Aarhus, Denmark

* To whom correspondence should be addressed. E-mail: signegjedde{at}dadlnet.dk.

Context: An interaction between ghrelin, which is implicated in the regulation of short- and long-term energy balance, and thyroid function has been reported in hyperthyroidism where ghrelin levels are reversibly suppressed. We measured serum ghrelin levels and metabolic indices in hypothyroid patients before and after L-thyroxin replacement.

Patients and methods: Eleven patients were examined twice: 1) in the hypothyroid state, and 2) after at least 2 months of euthyroidism. Ten healthy subjects served as a control group. Ghrelin was measured in conjunction with indirect calorimetry and a hyperinsulinemic euglycemic clamp.

Results: Serum ghrelin levels were increased by 32% under basal conditions in the hypothyroid state (PRE) as compared to post treatment (POST) (pg/ml): 976.4 ± 80.8 vs. 736.8 ± 67.1 (p < 0.001). This difference prevailed during the clamp but a decline was observed in both states: 641.4 ± 82.2 vs. 444.3 ± 66.8 µg/ml (p = 0.005). The hypothyroid state was associated with decreased resting energy expenditure, increased respiratory quotient and insulin resistance. Serum ghrelin levels as well as the metabolic aberrations became normalized after L-thyroxin replacement as compared to the control subjects.

Conclusion: serum ghrelin levels are reversibly increased in hypothyroid patients. It remains to be investigated whether this represents a direct effect of iodothyronines on ghrelin secretion or clearance, or a compensatory response to the abnormal energy metabolism in hypothyroid patients.


Key words: hypothyroidism • ghrelin • energy expenditure







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society